Cargando…

1,25-Dihydroxyvitamin D Inhibits Osteoarthritis by Modulating Interaction Between Vitamin D Receptor and NLRP3 in Macrophages [Retraction]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236430/ https://www.ncbi.nlm.nih.gov/pubmed/35769127 http://dx.doi.org/10.2147/JIR.S379384

Ejemplares similares

1,25-Dihydroxyvitamin D Inhibits Osteoarthritis by Modulating Interaction Between Vitamin D Receptor and NLRP3 in Macrophages
por: Duan, Ao, et al.
Publicado: (2021)

The relationship of 1,25-dihydroxyvitamin D and Vitamin D binding protein in periodontitis
por: Rafique, Sara, et al.
Publicado: (2019)

Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
por: Dusso, Adriana S
Publicado: (2011)

Familial vitamin D resistant rickets: End-organ resistance to 1,25-dihydroxyvitamin D
por: Choudhury, Sangita, et al.
Publicado: (2013)

1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages
por: Heulens, Nele, et al.
Publicado: (2016)

Paracrine interactions between mesenchymal stem cells and macrophages are regulated by 1,25-dihydroxyvitamin D3
por: Saldaña, Laura, et al.
Publicado: (2017)

Vitamin D, 1,25-Dihydroxyvitamin D, FGF23, and Graft Function after Renal Transplantation
por: Mehrotra, Sonia, et al.
Publicado: (2019)

Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling
por: Chun, Rene F., et al.
Publicado: (2012)

Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D
por: Cirillo, Massimo, et al.
Publicado: (2019)

THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
por: Brown, Jeremy, et al.
Publicado: (2023)

Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D(3), 1,25-Dihydroxyvitamin D(3) and 24R,25-Dihydroxyvitamin D(3)
por: van der Meijden, Karen, et al.
Publicado: (2014)

The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.
por: Hickish, T., et al.
Publicado: (1993)

Vitamin D deficiency increases vulnerability to canagliflozin-induced adverse effects on 1,25-dihydroxyvitamin D and PTH
por: Yazdi, Zhinous Shahidzadeh, et al.
Publicado: (2023)

Serum 1,25-Dihydroxyvitamin D: An Outcome Prognosticator in Human Sepsis
por: Nguyen, H. Bryant, et al.
Publicado: (2013)

Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
por: Faye, Pierre Antoine, et al.
Publicado: (2019)

Publisher Correction: Paracrine interactions between mesenchymal stem cells and macrophages are regulated by 1,25-dihydroxyvitamin D3
por: Saldaña, Laura, et al.
Publicado: (2018)

Publisher Correction: Paracrine interactions between mesenchymal stem cells and macrophages are regulated by 1,25-dihydroxyvitamin D3
por: Saldaña, Laura, et al.
Publicado: (2018)

8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D(3)-induced growth inhibition without affecting 1,25-dihydroxyvitamin D(3)-stimulated differentiation of primary mouse epidermal keratinocytes
por: Bollag, Wendy B, et al.
Publicado: (2004)

Vitamin D Status among Thai School Children and the Association with 1,25-Dihydroxyvitamin D and Parathyroid Hormone Levels
por: Houghton, Lisa A., et al.
Publicado: (2014)

1,25-Dihydroxyvitamin D Deficiency Accelerates Aging-related Osteoarthritis via Downregulation of Sirt1 in Mice
por: Chen, Jie, et al.
Publicado: (2023)

25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, and Peripheral Bone Densitometry in Adults with Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2020)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria
por: Ma, Jianchao, et al.
Publicado: (2013)

Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-γ in Human Macrophages after Mycobacterial Infection
por: Lee, Ji-Sook, et al.
Publicado: (2009)

Role of 25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) in Chicken Embryo Osteogenesis, Adipogenesis, Myogenesis, and Vitamin D(3) Metabolism
por: Chen, Chongxiao, et al.
Publicado: (2021)

Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3
por: Halicka, H. Dorota, et al.
Publicado: (2012)

Mechanistic study of the cause of decreased blood 1,25-Dihydroxyvitamin D in sepsis
por: Li, Chih-Huang, et al.
Publicado: (2019)

25-Hydroxyvitamin D(3) and 1,25-Dihydroxyvitamin D(3) Promote the Differentiation of Human Subcutaneous Preadipocytes
por: Nimitphong, Hataikarn, et al.
Publicado: (2012)

1,25-Dihydroxyvitamin D3 modulates the phenotype and function of Monocyte derived dendritic cells in cattle
por: Corripio-Miyar, Yolanda, et al.
Publicado: (2017)

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study
por: Gilbert, Rebecca, et al.
Publicado: (2014)

Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D(3) in breast cancer
por: Narvaez, Carmen J., et al.
Publicado: (2020)

1,25-Dihydroxyvitamin D3 suppresses CD4(+) T-cell effector functionality by inhibition of glycolysis
por: Bishop, Emma L., et al.
Publicado: (2022)

1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism
por: Christensen, Monika H. E., et al.
Publicado: (2013)

No major effects of vitamin D(3) (1,25 dihydroxyvitamin D(3)) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers
por: Kullak-Ublick, Gerd A., et al.
Publicado: (2016)

1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma
por: Rodríguez-Gutiérrez, René, et al.
Publicado: (2014)

Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
por: Jeffery, Louisa E., et al.
Publicado: (2018)

Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy
por: Zeng, Xiaoyun, et al.
Publicado: (2017)

SAT-356 Reversible Suppression of Serum 1,25-Dihydroxyvitamin D in Williams Syndrome
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

Severe Hypercalcemia From Inhalation Pneumonitis via Activation of 1,25 Dihydroxyvitamin D
por: Rosenstein, Kyle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_au7f1oo4g3sb9n9ghhibhjpgrt